A new study from the Regulatory Science Group highlights key challenges and solutions.
Emerging technologies such as genome editing and engineered gene drive hold immense promise for addressing some of Africa’s most pressing challenges, from improving agricultural yields to eradicating disease vectors. The latest study by the Regulatory Science Group, however, reveals that fragmented biosafety regulatory frameworks are stalling progress in many African nations.
The research published in Frontiers in Bioengineering and Biotechnology, explores current regulatory gaps and highlights the pressing need for capacity building, international collaboration, and adaptive, context-specific regulatory models.
Key recommendations from the study include offering innovative training programmes for regulators, fostering global partnerships, adopting best practices from regional leaders such as Nigeria and Kenya, and engaging the public through transparent communication.
The authors propose that by harmonising regulatory standards and enhancing stakeholder participation, the continent can better navigate the complexities of these emerging biotechnologies.
For a detailed look at our findings and recommendations, read the full study here: https://doi.org/10.3389/fbioe.2024.1483279